Antimicrobial Stewardship Program Implementation in Brazilian Public Hospitals (PeGASUS)
NCT07514884 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54
Last updated 2026-04-07
Summary
Antimicrobial resistance is a major global public health challenge, leading to increased morbidity, mortality, and healthcare costs. Antimicrobial Stewardship Programs (ASPs) are recognized as an effective strategy to improve the appropriate use of antimicrobials and to reduce the emergence of resistant microorganisms. However, despite national guidelines, many hospitals-especially in low- and middle-income settings-face important barriers to implementing and sustaining these programs.
The PeGASUS study is a nationwide, multicenter implementation initiative designed to support and strengthen ASPs in Brazilian public hospitals. The study will include approximately 54 hospitals across all five regions of Brazil that either do not have an ASP or have programs classified as inadequate or basic.
This is a pragmatic, quasi-experimental before-and-after study with historical control, conducted over approximately 21 months. The intervention combines multiple strategies to address common implementation barriers, including a structured web-based training program, engagement of hospital leadership, development of locally tailored ASP action plans, ongoing technical support, and collaborative learning between participating hospitals.
The study is organized into four phases: (1) pre-intervention (baseline), (2) intervention, (3) follow-up, and (4) wrapping up. During the baseline phase, data on hospital characteristics, antimicrobial use, and ASP organization are collected. During the intervention phase, hospitals receive training and support to implement ASP activities adapted to their local context. The follow-up phase evaluates the sustainability of the implemented strategies under routine conditions.
Outcomes include changes in the level of ASP implementation, antimicrobial consumption (measured as defined daily doses per 1,000 patient-days), number and acceptance of stewardship interventions, and clinical outcomes such as length of hospital stay and 30-day mortality. Additionally, a cost-effectiveness analysis will be conducted in a subset of hospitals.
All data are collected at the hospital level in aggregated form, without identifying individual patients, ensuring confidentiality and minimizing risks.
By combining capacity building, standardized tools, and continuous support, the PeGASUS study aims to bridge the gap between national antimicrobial stewardship guidelines and real-world practice. The findings are expected to provide evidence on scalable strategies to improve antimicrobial use and strengthen healthcare systems, particularly in resource-limited settings.
Conditions
- Antimicrobial Stewardship Program
- Resistance Bacterial
Interventions
- OTHER
-
ASP implementation
The PeGASUS intervention is a multifaceted implementation strategy to support the development of Antimicrobial Stewardship Programs (ASPs) in Brazilian public hospitals. Delivered over 10 months, it combines: (1) a structured web-based training program with five modules; (2) development of a locally tailored ASP implementation plan based on national guidelines; (3) engagement of hospital leadership and formation of multidisciplinary ASP teams; (4) ongoing technical support through monthly virtual meetings and at least one on-site visit; (5) collaborative learning and benchmarking sessions across hospitals; and (6) standardized monitoring of antimicrobial use and stewardship activities. This intervention integrates education, mentorship, and locally adapted implementation strategies, aiming to enable hospitals with limited resources to transition from passive antimicrobial monitoring to active stewardship practices.
Sponsors & Collaborators
-
ANVISA
collaborator UNKNOWN -
Hospital Alemão Oswaldo Cruz
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-01
- Primary Completion
- 2026-09-20
- Completion
- 2026-10-01
Countries
- Brazil
Study Locations
More Related Trials
-
NAsal MEthicillin-resistant Staphylococcus (NAMES): a Prospective Study to Assess the Impact of Antibiotic Therapy on Nasal Colonization with Methicillin-resistant Staphylococcus Aureus (MRSA) Inhospitalized Children
NCT06872099 ·Status: RECRUITING
-
Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia
NCT00548002 ·Status: COMPLETED
-
Epidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the Community
NCT00966446 ·Status: COMPLETED ·Phase: NA
-
Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.
NCT05282082 ·Status: COMPLETED
-
Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers
NCT04659941 ·Status: UNKNOWN ·Phase: PHASE2
-
A Mobile App Serious Game to Increase Awareness of Antibiotic Use in the Community
NCT05445414 ·Status: COMPLETED ·Phase: NA
-
Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections
NCT00156377 ·Status: COMPLETED ·Phase: PHASE4
-
Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers
NCT00778388 ·Status: COMPLETED ·Phase: PHASE1
-
An Evaluation Of Respiratory Samples for Staphylococcus Resistance PatternsS
NCT00754273 ·Status: COMPLETED
-
Clinical Efectiveness of a Multiplex PCR-Based Rapid Diagnostic Method in Bloodstream Infections
NCT07408544 ·Status: RECRUITING
-
Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies
NCT04335383 ·Status: RECRUITING
-
Effect of Metallic Nanoparticles on Nosocomial Bacteria
NCT04775238 ·Status: UNKNOWN ·Phase: NA
-
Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant
NCT00518076 ·Status: UNKNOWN
-
Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus)
NCT01589185 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Impact MRSA -PCR on Patient Management
NCT03096405 ·Status: COMPLETED
-
A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients
NCT01234831 ·Status: COMPLETED ·Phase: NA
-
Study of the Effect of Systematic Screening of Residents and Caregivers With Covid-19 by Nasopharyngeal Swab (RT-PCR)
NCT05085522 ·Status: UNKNOWN
-
Repurposing Clinically Approved Drugs for Yaws with an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep-AByaws)
NCT05764876 ·Status: COMPLETED ·Phase: PHASE3
-
Viral Load Analysis of the SARS-CoV-2 Virus in Nose Versus Mouth Sites
NCT05769803 ·Status: UNKNOWN ·Phase: NA
-
A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA
NCT07362693 ·Status: RECRUITING
-
The Efficacy and Adverse Reactions of Neotetracycline in the Treatment of GNB Infections
NCT06990126 ·Status: ENROLLING_BY_INVITATION
-
mexB Efflux Pump Gene Expression, Activity and Biofilm Formation in Clinical Isolates of Pseudomonas Aeruginosa
NCT07469436 ·Status: NOT_YET_RECRUITING
-
Antimicrobial Drug Use and Resistant Staphylococcus Aureus
NCT01075451 ·Status: COMPLETED
-
Staphylococcus Aureus Bacteraemia in Adults
NCT02098850 ·Status: UNKNOWN
-
S. Aureus Screening and Decolonization
NCT02182115 ·Status: COMPLETED ·Phase: PHASE4